BPC-157
Also known as Body Protection Compound-157, Pentadecapeptide BPC 157
A synthetic peptide derived from a protein found in human gastric juice. Extensive preclinical studies demonstrate efficacy in healing tendons, ligaments, muscles, and the GI tract.
Regulatory Pathway
Dosing Protocol
Typical Dose
250-500 mcg twice daily
Frequency
1-2x daily
Duration
4-12 weeks
Timing & Administration
Administer via Subcutaneous injection. Frequency: 1-2x daily.
Popular Uses
Mechanism of Action
Modulates nitric oxide signaling, stimulates new blood vessel development, upregulates growth hormone receptors, engages dopaminergic pathways, and enhances collagen synthesis for accelerated tendon-to-bone healing.
Research Summary
Evidence level: animal studies. Clinical status: Preclinical - FDA Category 2 (restricted from compounding as of September 2023).
Side Effects & Safety
Important Warnings
- Caution with MCAS or histamine sensitivity
- Restricted from compounding as of September 2023.
References
No references available.
Related Peptides
Browse all →A synthetic 17-amino acid fragment of Thymosin Beta-4 with a longer half-life (~2-4 days) compared to the full protein (~2 hours).
View profileA naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Widely used in skincare for its wound healing and anti-aging properties.
View profileThe full 15-amino acid sequence containing BPC-157, derived from gastric juice with comparable healing properties.
View profile